Laboratory:Akiruno
- TOP
- serum immunological test
- plasma proteins
Laboratory:Akiruno
○plasma proteins
TEST NAME |
SPECIMEN REQUIREMENT (mL) |
CONTAINER | CAP COLOR | STORE TEMPERATURE (STABILITY) |
TURNAROUND TIME (DAY) |
METHODOLOGY | REFERENCE RANGE (UNIT) |
---|---|---|---|---|---|---|---|
Prealbumin
|
Serum
0.5 |
S09 ↓ A00 |
|
2-4 |
immunoturbidimetric method TIA (Turbidimetric immnoassay) |
22.0-40.0(mg/dL) | |
α1-Microglobulin
|
Serum
0.5 |
S09 ↓ A00 |
|
2-4 | Latex agglutination immunoassay |
M12.5-25.5 F11.0-19.0(mg/L) |
|
α1-Microglobulin
|
Partial urine
0.5 |
U00 |
|
2-4 | Latex agglutination immunoassay |
M1.0-15.5 F0.5-9.5(mg/L) |
|
α1-Antitrypsin
|
Serum
0.4 |
S09 ↓ A00 |
|
2-4 |
Nephelometry Nephelometry |
94-150(mg/dL) | |
α1-acidglycoprotein
|
Serum
0.4 |
S09 ↓ A00 |
|
2-4 |
Nephelometry Nephelometry |
M45-98 F39-86(mg/dL) |
|
Retinol binding protein (RBP)
|
Serum
0.5 |
S09 ↓ A00 |
|
2-4 |
Latex agglutination turbidimetry LA (Latex agglutination immunoassay) |
M2.7-6.0 F1.9-4.6(mg/dL) |
|
α2-macroglobulin
|
Serum
0.4 |
S09 ↓ A00 |
|
2-4 |
Nephelometry Nephelometry |
M100-200 F130-250(mg/dL) |
|
Haptoglobin
|
Serum
0.5 |
S09 ↓ A00 |
|
2-4 |
Nephelometry Nephelometry |
Type 1-1 83-209 Type 2-1 66-218 Type 2-2 25-176 (mg/dL) |
|
Ceruloplasmin
|
Serum
0.4 |
S09 ↓ A00 |
|
2-4 |
Nephelometry Nephelometry |
21-37(mg/dL) | |
Transferrin
|
Serum
0.5 |
S09 ↓ A00 |
|
2-4 |
immunoturbidimetric method TIA (Turbidimetric immnoassay) |
M190-300 F200-340(mg/dL) |
|
Urinary transferrin
|
Urine storage
0.5 |
U00 |
(1 month) |
2-4 |
Latex agglutination turbidimetry LA (Latex agglutination immunoassay) |
0.80 or less (mg/day) | |
Urinary transferrin (creatinine ratio)
|
Partial urine
1 |
U00 |
(1 month) |
2-4 |
Latex agglutination turbidimetry LA (Latex agglutination immunoassay) |
Urinary transferrin ratio 1.00 or less (mg/g・CRE) | |
β2-microglobulin
|
Serum
0.5 |
S09 ↓ A00 |
|
2-4 | Latex agglutination immunoassay | 1.0-1.9(mg/L) | |
β2-microglobulin
|
Urine storage
0.5 |
U00 |
|
2-4 | Latex agglutination immunoassay | 230 or less (μg/L) | |
β2-microglobulin
|
Partial urine
0.5 |
U00 |
|
2-4 | Latex agglutination immunoassay | 230 or less (μg/L) | |
C-reactive protein (CRP) quantitative
|
Serum
0.6 |
S09 ↓ A00 |
|
2-4 |
Latex agglutination turbidimetry LA (Latex agglutination immunoassay) |
0.14 or less (mg/dL) | |
Pentraxin 3 (PTX3)
|
Plasma 0.3 |
PN2,PN5 ↓ A00 |
|
3-16 |
ELISA ELISA (Enzyme-Linked immunosorbent assay) |
0.73-5.49(ng/mL) | |
Serum amyloid A protein (SAA)
|
Serum
0.5 |
S09 ↓ A00 |
(28 days) |
2-4 | Latex agglutination immunoassay | 3.0 or less (mg/L) | |
Myoglobin
|
Serum
0.5 |
S09 ↓ A00 |
|
2-4 |
CLIA CLIA (Chemiluminescent immunoassay) |
Male: 154.9 or less Female: 106.0 or less (ng/mL) |
|
Urinary myoglobin 〔CLEIA〕
|
Partial urine
6 |
U50 |
(22 days) |
2-4 |
CLEIA CLEIA (Chemiluminescent enzyme immunoassay) |
Less than 2.0(ng/mL) | |
Heart-type Fatty Acid Binding Protein(H-FABP)
|
Serum
0.5 |
S09 ↓ A00 |
(28 days) |
2-4 | latex agglutination method | Less than 6.2 (ng/mL) | |
Ventricular myosin light chain I
|
Serum
0.5 |
S09 ↓ A00 |
|
2-6 |
Enzyme immunoassay(EIA) EIA (Enzyme immunoassay) |
2.5 or less (ng/mL) | |
Myocardial troponin T
|
Serum
0.5 |
S09 ↓ A00 |
(14 days) |
2-4 |
ECLIA ECLIA (Electro chemiluminescence immunoassay) |
0.014 or less Cutoff value for acute myocardial infarction diagnosis 0.100 (ng/mL) |
|
Ferritin
|
Serum
0.4 |
S09 ↓ A00 |
|
2-4 |
CLEIA CLEIA (Chemiluminescent enzyme immunoassay) |
M39.4-340F3.6-114(ng/mL) | |
Liver-type Fatty Acid Binding Protein (L-FABP)〔CLEIA〕
|
Partial urine
2.0 |
U00 |
(14 days) |
2-4 |
CLEIA CLEIA (Chemiluminescent enzyme immunoassay) |
L-FABP creatinine ratio 8.4 or less (μg/gCr) | |
Urinary NGAL
|
Partial urine
2.0 |
↓ U00 |
(7 days) |
2-4 |
CLIA CLIA (Chemiluminescent immunoassay) |
30.5 or less (ng/mL) Creatinine ratio 21.7 or less (μg/gCr) |
|
Fetal human cancer fibronectin
|
vaginal secretions
|
VP5 |
(1 month) |
2-4 |
ELISA ELISA (Enzyme-Linked immunosorbent assay) |
Negative | |
Type I procollagen-N-propeptide (total P1NP)
|
Serum
0.4 |
S09 ↓ A00 |
(28 days) |
2-4 |
ECLIA ECLIA (Electro chemiluminescence immunoassay) |
Men (30-83 years old) 18.1-74.1 Premenopausal women (30-44 years old) 16.8-70.1 Postmenopausal women (45-79 years old) 26.4-98.2 (ng/mL) |
|
Type I collagen cross-linked N-telopeptide (NTx)
|
Partial urine
3 |
U00 |
|
2-4 |
CLEIA CLEIA (Chemiluminescent enzyme immunoassay) |
See below | |
Type I collagen cross-linked N-telopeptide (NTx) (osteoporosis)
|
Partial urine
3 |
U00 |
|
2-4 |
CLEIA CLEIA (Chemiluminescent enzyme immunoassay) |
Male 13.0-66.2 Premenopausal female 9.3-54.3 Postmenopausal female 14.3-89.0 (Reference value) (nmolBCE/mmol・CRE) Criteria: See below |
|
Type I collagen C-terminal telopeptide (I CTP)
|
Serum
0.3 |
S09 ↓ A00 |
|
2-4 |
RIA2 antibody method RIA (Radio immunoassay) |
Less than 4.5 (ng/mL) | |
Mac-2 binding protein glycosylation isomer (M2BPGi)
|
Serum
0.5 |
S09 ↓ A00 |
|
2-4 |
CLEIA CLEIA (Chemiluminescent enzyme immunoassay) |
(-) refer to the following | |
Autotaxin
|
Serum
0.5 |
S09 ↓ A00 |
(21 days) |
2-4 |
CLEIA CLEIA (Chemiluminescent enzyme immunoassay) |
See below.(mg/L) | |
Procollagen III peptide (P-III-P)〔CLIA〕
|
Serum
0.5 |
S09 ↓ A00 |
|
2-4 |
CLIA CLIA (Chemiluminescent immunoassay) |
3.62-9.52(ng/mL) | |
Type IV Collagen
|
Serum
0.4 |
S09 ↓ A00 |
|
2-4 |
Latex agglutination turbidimetry LA (Latex agglutination immunoassay) |
150 or less (ng/mL) | |
Urinary type IV collagen
|
Partial urine
5 |
U70 |
(1 month) |
3-9 |
Enzyme immunoassay(EIA) EIA (Enzyme immunoassay) |
30-39 years old: 4.0 or less 40 years or older: 4.9 or less (μg/g・CRE) |
|
Collagen type Ⅳ/ 7S〔CLEIA〕
|
Serum
0.5 |
S09 ↓ A00 |
(23 days) |
2-4 |
CLEIA CLEIA (Chemiluminescent enzyme immunoassay) |
4.4 or less (ng/mL) | |
Cytokeratin-18 fragment (CK-18F)
|
Serum
0.3 |
S09 ↓ A00 |
(31 days) |
3-9 |
Enzyme immunoassay(EIA) EIA (Enzyme immunoassay) |
Less than 260 (cut-off value)(U/L) | |
Deoxypyridinoline
|
Partial urine
3 |
U00 |
|
2-4 |
Enzyme immunoassay(EIA) EIA (Enzyme immunoassay) |
Creatinine adjustment M 2.1 - 5.4 F 2.8 - 7.6 (nmol/mmol・CRE) |
|
Deoxypyridinoline (DPD) (osteoporosis)
|
Partial urine
3 |
U00 |
|
2-4 |
Enzyme immunoassay(EIA) EIA (Enzyme immunoassay) |
Creatinine conversion ratio M 2.1-5.4 F 2.8-7.6 (nmol/mmol・CRE) Judgment criteria: See below |
|
KL-6
|
Serum
0.5 |
S09 ↓ A00 |
|
2-4 |
CLEIA CLEIA (Chemiluminescent enzyme immunoassay) |
Less than 500 (U/mL) | |
Procalcitonin
|
Serum
0.4 |
S09 ↓ A00 |
(28 days) |
2-4 |
CLEIA CLEIA (Chemiluminescent enzyme immunoassay) |
0.05 or less (ng/mL) | |
Presepsin
|
Serum 0.4 |
S09 ↓ A00 |
(28 days) |
2-4 |
CLEIA CLEIA (Chemiluminescent enzyme immunoassay) |
Cutoff value for sepsis (bacterial) diagnosis 500 (pg/mL) |
|
Presepsin
|
Plasma 0.4 |
PH5 ↓ A00 |
(28 days) |
2-4 |
CLEIA CLEIA (Chemiluminescent enzyme immunoassay) |
Cutoff value for sepsis (bacterial) diagnosis 500 (pg/mL) |
|
|
Partial urine
6.0 |
U50 |
(21 days) |
2-5 |
RIA2 antibody method RIA (Radio immunoassay) |
10 or less (ng/mL) | |
|
Serum
0.2 |
SEC ↓ A00 |
|
2-8 |
FEIA FEIA (Fluorescence enzyme immunoassay) |
Adult 14.9 or less (μg/L) | |
|
Serum
0.3 |
S09 ↓ A00 |
|
2-4 |
RIA solid phase method IRMA (Immuno radio metric assay) |
0.3-0.8(U/mL) | |
|
Serum
0.5 |
S09 ↓ A00 |
|
3-5 |
RIA2 antibody method RIA (Radio immunoassay) |
6 or less (ng/mL) | |
|
Serum
0.6 |
S09 ↓ A00 |
(21 days) |
Please confirm in advance |
CDT: Nephelometry Transferrin: immunonephelometry |
%CDT 1.24-2.16 Cutoff value for alcoholic liver damage 2.00 (%) Transferrin M 190-300 F 200-340 (mg/dL) |